CLINICAL_TRIALS
trial_result
· 2026-03-03
Clinical Trial Update: A Study of LY3549492 in Chinese Participants With Type 2 Diabetes Mellitus [Phase 1]
Summary
A Phase 1 clinical trial evaluating LY3549492 in Chinese participants with Type 2 diabetes mellitus has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Type 2 Diabetes | Phase 1 | Status: COMPLETED